Session Information

Sponsored Seminar

[ILS-TH-14] Lunch Seminar 14: Ocular surface damaged by topical anti-glaucoma eye drops
Go back
print
Day
Apr 03 (Thu)
Time
12:15 - 13:15
Room
Room 19 - Imperial Hotel 2F Botan
Sponsor
Otsuka Pharmaceutical Co.,Ltd.
Topic
Glaucoma
Chair/Coordinator
Chair)Tetsuya Yamamoto
Description
Glaucoma treatment aims to preserve the visual field throughout a person’s lifetime. Therefore, new categories and fixed combinations of drugs have been used in addition to conventional β-blockers, CAIs, and PGs, and their combined therapy has been increased. However, the increased combined therapy of multiple drugs has raised concerns regarding long-term glaucoma treatment, because ingredients in eye drops may damage the ocular surface.Glaucoma and cornea specialists will discuss the optimal usage and combinations of ocular hypotensive medications available in Japan to minimize the incidence of ocular adverse effects and maintain patient comfort.

Go back